Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics. | Bioimpacts | 2023 | 37193075 | PubTator, text mining | PubMed |
| Integrative Analysis of the Predictive Value of Perilipin Family on Clinical Significance, Prognosis and Immunotherapy of Glioma. | Biomedicines | 2023 | 37189627 | PubTator, text mining | PubMed |
| Exploration and Clinical Verification of the Blood Co-Expression Genes of Type 2 Diabetes Mellitus and Mild Cognitive Dysfunction in the Elderly. | Biomedicines | 2023 | 37189611 | PubTator, text mining | PubMed |
| HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances. | Biomolecules | 2023 | 37189349 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety. | Bioorg Med Chem | 2023 | 37187077 | PubTator, text mining | PubMed |
| Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin. | Nat Commun | 2023 | 37185902 | PubTator, text mining | PubMed |
| Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches. | Chem Sci | 2023 | 37181765 | PubTator, text mining | PubMed |
| COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants. | Immune Netw | 2023 | 37179752 | PubTator, text mining | PubMed |
| From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID. | Int J Mol Sci | 2023 | 37175995 | PubTator, text mining | PubMed |
| Autophagy and SARS-CoV-2-Old Players in New Games. | Int J Mol Sci | 2023 | 37175443 | PubTator, text mining | PubMed |
| The miR-183 Cluster: Biogenesis, Functions, and Cell Communication via Exosomes in Cancer. | Cells | 2023 | 37174715 | PubTator, text mining | PubMed |
| Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis. | Int J Biol Sci | 2023 | 37151889 | PubTator, text mining | PubMed |
| Eukaryotic-like Phosphoprotein Phosphatase (PPP) enzyme evolution: interactions with environmental toxins and regulatory proteins. | Biosci Rep | 2023 | 37144562 | PubTator, text mining | PubMed |
| A Review of Extracellular Vesicles in COVID-19 Diagnosis, Treatment, and Prevention. | Adv Sci (Weinh) | 2023 | 37144543 | PubTator, text mining | PubMed |
| Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells. | Front Oncol | 2023 | 37139155 | PubTator, text mining | PubMed |
| Genetic comparison of transmissible gastroenteritis coronaviruses. | Front Vet Sci | 2023 | 37138909 | PubTator, text mining | PubMed |
| Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach. | In Silico Pharmacol | 2023 | 37131867 | PubTator, text mining | PubMed |
| Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase. | Virol Sin | 2023 | 37127212 | PubTator, text mining | PubMed |
| SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. | ACS Cent Sci | 2023 | 37122453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=15